Track the 3SBio Inc. share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Market capitalisation: €6.6bn. The latest transaction was reported on 7 September 2026 (Purchase). Among the most active insiders: Lou Jing. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
三生制药有限公司是一家中国生物制药公司,专注于生物产品的研究、开发和商业化。它主要针对肾脏疾病和血液疾病的治疗。